Neuralink updates
Real-Time Communication Restoration in ALS with a Fully Implanted Speech Brain-Computer Interface (opens in a new tab)
Early Neuralink speech restoration data shared during the 25th Annual Meeting of the Northeast ALS Consortium.
Pretraining on 50,000 Hours of Unlabeled Brain Data
How self-supervised encoders kept neural decoders working for weeks without recalibration and set an 11.32 BPS record.
Brain–computer interface clinical trial design considerations and clinical outcome assessments in pivotal studies (opens in a new tab)
A summary of the 11th BCI society meeting 2025 workshop.
Our First Transdural Procedure (opens in a new tab)
For the first time in our clinical trials, we inserted the electrode threads of our implant straight through the dura and into the cortex, keeping the dura intact.
Neuralink’s DJ Seo: Inside the Race to Connect Brains and AI (opens in a new tab)
DJ Seo, co-founder and president of Neuralink, joins Sequoia partner Shaun Maguire at AI Ascent 2026 to talk about what it takes to build the bridge between the human brain and AI.
Man given Musk’s Neuralink brain chip in UK trial says it ‘feels magical’ and gives new hope (opens in a new tab)
One of the first people in the UK to use Elon Musk’s brain chip says it “feels magical” and believes it could transform the lives of those with severe paralysis.
Two Years of Telepathy
Announcing 21 Neuralink participants.
The curse of dimensionality in motor cortex (opens in a new tab)
Here, we show that unsupervised estimates of dimensionality do not converge but instead scale with the number of recorded neurons.
Welcome, David McMullen!
We’re thrilled to welcome David McMullen to Neuralink.
Neuralink Overview, Fall 2025 (opens in a new tab)
DJ and our recruiting team visited several schools to provide an overview of Neuralink, including recent progress updates and an outline for the company’s path ahead.
Barrow Patient Controls Robotic Arm with Thought in CONVOY Study (opens in a new tab)
Alex, who has a cervical SCI, was the second patient to receive the N1 Implant at Barrow and overall. He is the first person to use the device to control an assistive robotic arm.
Neuralink Helps Mr. Smith See His Family Again (opens in a new tab)
Finding joy in small moments. That’s what Brad Smith is doing, with the help of Neuralink and Insta360 Link 2.
GB-PRIME Study Launch
We are excited to announce that we are launching the GB-PRIME study across two sites in Great Britain!
Neuralink Update, Summer 2025 (opens in a new tab)
A technical progress update from the Neuralink team.
datarepo - Neuralink's platform for complex data
Neuralink launches datarepo - an open-source data platform for multimodal data management. This is the first component of the platform - the data catalog.
Neuralink raises $650M Series E
Our $650M Series E will expand patient access to our technology and push the boundaries of what’s possible with brain interfaces.
Building Safe Implantable Devices
In this blog post, we highlight several techniques we use to confirm the safety of our implants prior to launching clinical trials.
Mr. Smith Gets a Neuralink Brain Implant (opens in a new tab)
The before and after journey of a family using tech to battle ALS.
Neuralink Receives Breakthrough Device Designation for Speech
We've received Breakthrough Device Designation from the FDA to help restore communication for individuals with severe speech impairment.
One Year Later: First Neuralink Implant Patient Shares Story (opens in a new tab)
In January 2024, Noland underwent neurosurgery at Barrow Neurological Institute in Phoenix, Arizona, becoming the first person to receive Neuralink’s N1 Implant as part of the PRIME Study.
A Year of Telepathy
Over the past year, three people with paralysis have received Neuralink implants. This blog post explores how each person is using Telepathy in everyday life.
CONVOY Study Launch
We’re excited to announce the launch of a new feasibility trial to extend BCI control using the N1 Implant to an investigational assistive robotic arm.
CAN-PRIME Study Launch
We are excited to announce that we have received approval from Health Canada to launch the CAN-PRIME Study, our first international trial!
Neuralink Receives Breakthrough Device Designation for Blindsight
We are excited to announce that we have received Breakthrough Device Designation from the FDA for Blindsight! For individuals with vision impairment.
PRIME Study Progress Update — Second Participant
Our technology is enabling our second PRIME Study participant to play video games and use CAD software. This post shares updates on his experience.
Elon Musk: Neuralink and the Future of Humanity (opens in a new tab)
Lex Fridman speaks with the Neuralink team.
Neuralake - Complex Data, Simple Systems (opens in a new tab)
Enabling telepathy and vision restoration is no simple task, and Neuralink’s data reflects that. Neuralink manages a tightly-woven, sprawling web of information, connecting neural signals, manufacturing telemetry, in vivo study results, and more.
Neuralink Update (opens in a new tab)
The Neuralink team shares an update on the progress of the first Neuralink study participant and changes made in advance of the second participant.
Sitting down with Neuralink’s 1st brain chip implant patient (opens in a new tab)
ABC News correspondent Will Reeve shares a look at his exclusive interview with Neuralink’s first brain chip implant patient.
PRIME Study Progress Update — User Experience
We’ve just passed 100 days since the first participant in our clinical trial received his Neuralink implant. Read our latest progress update.
PRIME Study Progress Update
In January, we conducted the first human implantation of our brain-computer interface. This blog post shares a high-level snapshot of where we are as a company.
Neuralink’s Patient Registry Opens to Canada
In Neuralink's first international expansion, our Patient Registry is now accepting applications from Canadian residents.
Understanding Preclinical Research at Neuralink
Become acquainted with the Preclinical Team, which is responsible for the design, conduct, documentation, analysis, and reporting of preclinical studies.
Neuralink’s First-in-Human Clinical Trial is Open for Recruitment
We are happy to announce that we've received approval to begin recruitment for our first-in-human trial at our first hospital site.
Neuralink Raises $280M Series D
We’re happy to announce our $280M Series D round led by Founders Fund. We’re extremely excited about this next chapter at Neuralink.
The Role of the Institutional Animal Care and Use Committee
We explore the functions of Neuralink’s Institutional Animal Care and Use Committee (IACUC) and its role in promoting refinement, reduction, and replacement.
Neuralink & Technologies to Enhance Human Brains | Dr. Matthew MacDougall (opens in a new tab)
Andrew Huberman speaks with Matthew MacDougall, Head Neurosurgeon at Neuralink.
Environmental Enrichment
In our second blog on refinement, we highlight our methodology to ensure that we provide an enriching environment and experience to animals within our care.
Announcing Neuralink's Patient Registry
We’ve launched a Patient Registry to learn more about individuals who may be interested in enrolling in future Neuralink clinical trials.
Husbandry Refinement
The first episode of our Refinement Series will look at how we evaluate the well-being of an animal as it pertains to housing, food, and water.
Neuralink Show and Tell, Fall 2022 (opens in a new tab)
A technical progress update from the Neuralink team.
Championing the 3 Rs
We hope you will take this opportunity to learn alongside us as we dive into the complex world of ensuring animal well-being in a research setting.
Neuralink's Commitment to Animal Welfare
Animals at Neuralink are respected and honored by our team. In this blog post, we provide an accurate statement of Neuralink’s commitment to animal welfare.
Series C Funding Round Announcement
Neuralink is pleased to announce our Series C funding round of $205 million. Neuralink is developing brain-computer interfaces to treat brain related ailments.
A 1024-Channel Simultaneous Recording Neural SoC with Stimulation and Real-Time Spike Detection (opens in a new tab)
In this paper we present a 5×4mm2 neural system-on-chip (SoC) capable of recording and stimulating from 1024 implanted electrodes via a serial digital link.
Pager Plays MindPong
Neuralink is developing a brain-computer interface to enable people with paralysis to use their neural activity to operate computers and mobile devices.
Neuralink Progress Update, Summer 2020 (opens in a new tab)
A technical progress update from the Neuralink team.
An Integrated Brain-Machine Interface Platform With Thousands of Channels (opens in a new tab)
In this white paper, we describe Neuralink’s first steps toward a scalable high-bandwidth brain-machine interface system.
Neuralink Launch Event (opens in a new tab)
Introducing Neuralink.